Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 46 Carcinoma, Transitional Cell 3 Urologic Diseases 2 Urinary Bladder Diseases 2 Muscle Invasive Bladder Cancer 2 Infiltrating Bladder Urothelial Carcinoma 2 Carcinoma, Renal Cell 2 Wound Infection 1 Urologic Neoplasms 1 Urinary Tract Infections 1 Ureteral Neoplasms 1 Transitional Cell Carcinoma of the Bladder 1 Transitional Cell Bladder Cancer 1 Stage 0is Bladder Urothelial Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Patient Satisfaction 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non-metastatic Muscle Invasive Bladder Cancer 1 Neoplasms 1 Invasive Bladder Cancer 1 Infections 1 Ileus 1 Disease Progression 1 Cross Infection 1 Cone Dystrophy 3 1 Bladder Adenocarcinoma 1 Bacterial Infections 1 Adrenal Gland Neoplasms 1

Interventions

pembrolizumab 185 Gemcitabine 170 Paclitaxel 152 Carboplatin 137 Bevacizumab 128 Surveys and Questionnaires 118 Cisplatin 115 Docetaxel 114 Blood Specimen Collection 110 Cyclophosphamide 109 Exercise 108 Nivolumab 98 Fluorouracil 90 Capecitabine 86 Dexamethasone 81 Radiotherapy 80 Irinotecan 74 Standard of Care 69 Pemetrexed 68 Oxaliplatin 68 Leucovorin 64 Drug Therapy 64 Cetuximab 60 Erlotinib Hydrochloride 56 Sorafenib 53 atezolizumab 52 Ipilimumab 51 Doxorubicin 50 trametinib 47 Interviews as Topic 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Cystectomy × Clear all

NCT04900558 2021-05-25

Robotic Radical Cystectomy Outcomes

University of Florence

Urinary Bladder Neoplasms, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡